{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:51:43Z","timestamp":1787237503245,"version":"build-2736575974"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.ijantimicag.2013.04.020","type":"journal-article","created":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T03:11:59Z","timestamp":1370401919000},"page":"182-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Anti-inflammatory and immunomodulatory activities of rifamycin SV"],"prefix":"10.1016","volume":"42","author":[{"given":"Caridad","family":"Rosette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Fernando","family":"Buendia-Laysa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Patkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Celasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Bozzella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Ajani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Gerloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl.","key":"10.1016\/j.ijantimicag.2013.04.020_bib0005","first-page":"951","article-title":"A review","volume":"15","author":"Bergamini","year":"1965","journal-title":"Arzneimittelforschung"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2013.04.020_bib0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000081990","article-title":"Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential","volume":"51","author":"Scarpignato","year":"2005","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2013.04.020_bib0015","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/030006059702500601","article-title":"Twenty years of experience with intra-articular rifamycin for chronic arthritides","volume":"25","author":"Caruso","year":"1997","journal-title":"J Int Med Res"},{"key":"10.1016\/j.ijantimicag.2013.04.020_bib0020","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1023\/A:1027314419843","article-title":"Rifamycins inhibit human neutrophil functions: new derivatives with potential antiinflammatory activity","volume":"21","author":"Spisani","year":"1997","journal-title":"Inflammation"},{"key":"10.1016\/j.ijantimicag.2013.04.020_bib0025","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000068362","article-title":"Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis","volume":"66","author":"Fiorucci","year":"2002","journal-title":"Digestion"},{"key":"10.1016\/j.ijantimicag.2013.04.020_bib0030","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S1873-9946(09)60335-4","article-title":"Evaluation of the activity in DNB-induced colitis in rats and on IFN\u03b3 production in ConA-stimulated rat splenocytes","volume":"3","author":"Quattrocchi","year":"2009","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.ijantimicag.2013.04.020_bib0035","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1179\/joc.2004.16.4.357","article-title":"Immunomodulating activity of rifampicin","volume":"16","author":"Ziglam","year":"2004","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2013.04.020_bib0040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ijantimicag.2008.10.007","article-title":"Immunoregulatory activity of rifaximin associated with a resistant mutant of Bifidobacterium infantis","volume":"33","author":"Vitali","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2013.04.020_bib0045","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00011-012-0533-8","article-title":"Characterization of lipopolysaccharide-stimulated cytokine expression in macrophages and monocytes","volume":"61","author":"Huang","year":"2012","journal-title":"Inflamm Res"},{"key":"10.1016\/j.ijantimicag.2013.04.020_bib0050","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10620-006-9320-0","article-title":"Phytic acid modulates in vitro IL-8 and IL-6 release from colonic epithelial cells stimulated with LPS and IL-1\u03b2","volume":"52","author":"Weglarz","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ijantimicag.2013.04.020_bib0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ajg.2011.355","article-title":"The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis","volume":"107","author":"Menees","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ijantimicag.2013.04.020_bib0060","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ajg.2011.72","article-title":"Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis","volume":"106","author":"Khan","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ijantimicag.2013.04.020_bib0065","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00535-011-0379-9","article-title":"Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review","volume":"46","author":"Ford","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.ijantimicag.2013.04.020_bib0070","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/AAC.00688-10","article-title":"In vitro activity and single-step mutational analysis of rifamycin SV tested against enteropathogens associated with traveler's diarrhea and Clostridium difficile","volume":"55","author":"Farrell","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.04.020_bib0075","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/00365520802321204","article-title":"Involvement of central immunity in uncomplicated diverticular disease","volume":"44","author":"Cianci","year":"2009","journal-title":"Scand J Gastroenterol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913001519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913001519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T09:57:43Z","timestamp":1539597463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857913001519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0924857913001519"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.04.020","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718194480.793487755","asserted-by":"object"}]},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-inflammatory and immunomodulatory activities of rifamycin SV","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}